X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (26) 26
oncology (17) 17
index medicus (15) 15
animals (13) 13
male (13) 13
mice (12) 12
cell line, tumor (11) 11
female (11) 11
surgery (10) 10
tumors (8) 8
xenograft model antitumor assays (8) 8
analysis (7) 7
erlotinib (7) 7
middle aged (7) 7
mutation (7) 7
aged (6) 6
lung cancer, non-small cell (6) 6
medicine & public health (6) 6
carcinoma, non-small-cell lung - pathology (5) 5
epidermal growth factor (5) 5
gene amplification (5) 5
genetic aspects (5) 5
health aspects (5) 5
hematology, oncology and palliative medicine (5) 5
lung cancer (5) 5
mice, inbred balb c (5) 5
therapy (5) 5
thoracic surgery (5) 5
acquired-resistance (4) 4
biochemistry & molecular biology (4) 4
cancer (4) 4
carcinoma, non-small-cell lung - drug therapy (4) 4
carcinoma, non-small-cell lung - genetics (4) 4
cardiac surgery (4) 4
genetics & heredity (4) 4
immunohistochemistry (4) 4
japan (4) 4
kinases (4) 4
mice, nude (4) 4
pharmacology & pharmacy (4) 4
proteins (4) 4
receptor, epidermal growth factor - genetics (4) 4
respiratory tract diseases (4) 4
treatment outcome (4) 4
tyrosine kinase inhibitor (4) 4
vascular surgery (4) 4
aged, 80 and over (3) 3
animal models (3) 3
antitumor-activity (3) 3
apoptosis (3) 3
association (3) 3
bevacizumab (3) 3
breast cancer (3) 3
cancer research (3) 3
case-control studies (3) 3
cell lung-cancer (3) 3
chemistry, multidisciplinary (3) 3
chemotherapy (3) 3
cytotoxicity (3) 3
erlotinib hydrochloride (3) 3
gefitinib (3) 3
gene mutations (3) 3
genetic linkage (3) 3
genetic predisposition to disease - genetics (3) 3
growth (3) 3
growth-factor receptor (3) 3
lung neoplasms - genetics (3) 3
lung neoplasms - pathology (3) 3
medical research (3) 3
monoclonal antibodies (3) 3
mutations (3) 3
non-small cell lung cancer (3) 3
open-label (3) 3
research (3) 3
surgical oncology (3) 3
thyroiditis, autoimmune - genetics (3) 3
tumor cell lines (3) 3
vascular endothelial growth factor (3) 3
1st-line treatment (2) 2
abdominal aortic aneurysm (2) 2
abdominal surgery (2) 2
adenocarcinoma (2) 2
adenocarcinomas (2) 2
adult (2) 2
angiogenesis (2) 2
anti-infective agents - administration & dosage (2) 2
antibodies (2) 2
antibodies, monoclonal - immunology (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antibody (2) 2
anticancer properties (2) 2
antigen (2) 2
antigens (2) 2
antigens, cd (2) 2
antigens, differentiation - genetics (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
articles (2) 2
bevacizumab - administration & dosage (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Ou, S. I and Camidge, D. R and Engelman, J and Clark, J and Tye, L and Wilner, K and Stephenson, P and Varella-Garcia, M and Iafrate, A and Shaw, A. T and Hainaut, P and Ma, X and Lacas, B and Tsao, M and Douillard, J and Rousseau, V and Dunant, A and Seymour, L and Filipits, M and Graziano, S and He, J and Yang, H and Deng, Q and He, P and Jiang, J and Zhao, M and Gu, X and Zheng, L and Pang, H and Zhou, J. X and Reinmuth, N and Scherer, S. J and Penzel, R and Schnabel, P and Meister, M and Kiemle-Kallee, J and Reuss, A and Fischer, J. R and Wolf, M and Thomas, M and von Laffert, M and Berg, E and Lenze, D and Lohneis, P and Hummel, M and Dietel, M and Han, X and Ma, L and Liu, Y and Zhang, N. N and Li, D and Shi, Y and Furugaki, K and Iwai, T and Moriya, Y and Fujimoto-Ouchi, K and Mok, T. S. K and Park, K and Geater, S. L and Agarwal, S and Han, M and Credi, M and McKee, K and Kuriyama, N and Slichenmyer, W and Tan, E. H and Greillier, L and Martel-Lafay, I and Arpin, D and Pourel, N and Chabaud, S and Lamy, R and Madroszyk, A and Fournel, P and Strom, H. H and Sundstrom, S and Helbekkmo, N and Bremnes, R and Aasebo, U and van Elmpt, W and Ollers, M and Dingemans, A. C and Lambin, P and De Ruysscher, D and Topkan, E and Parlak, C and Topuk, S and Ozyilkan, O and Uyterlinde, W and Vincent, A. D and Belderbos, J and Korse, T and Baas, P and van den Heuvel, M and Satouchi, M and Chiba, Y and Yamamoto, N and Nishimura, Y and Tsujino, K and Fujisaka, Y and ... and on behalf of The Mar-LC Collaborative Group
Annals of Oncology, ISSN 0923-7534, 09/2012, Volume 23, Issue suppl 9, pp. ix389 - ix399
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2015, Volume 51, pp. S115 - S115
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2014, Volume 25, Issue suppl_4, pp. iv421 - iv421
Abstract Aim: Erlotinib (ERL), a specific inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase, benefits patients with non-small cell lung... 
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2014, Volume 9, Issue 7, p. e101854
Polyplex micelles have demonstrated biocompatibility and achieve efficient gene transfection in vivo. Here, we investigated a polyplex micelle encapsulating... 
CANCER-PATIENTS | COLONY-STIMULATING FACTOR | DENDRITIC CELLS | SART3-DERIVED PEPTIDES | MULTIDISCIPLINARY SCIENCES | PANCREATIC-CANCER | IMMUNE ACTIVATION | PEGYLATED POLYPLEX | BLOCK-COPOLYMER | CYTOTOXIC T-LYMPHOCYTES | PERITONEAL DISSEMINATION | Antigens, Neoplasm - genetics | RNA-Binding Proteins - genetics | Antigens, Neoplasm - immunology | Granulocyte-Macrophage Colony-Stimulating Factor - metabolism | Mice, Inbred C57BL | RNA-Binding Proteins - immunology | Injections, Intraperitoneal | CD40 Ligand - immunology | Granulocyte-Macrophage Colony-Stimulating Factor - genetics | Cancer Vaccines - immunology | Animals | CD40 Ligand - metabolism | Granulocyte-Macrophage Colony-Stimulating Factor - immunology | CD40 Ligand - genetics | Micelles | Antigens, Neoplasm - metabolism | Female | Mice | Mice, Inbred BALB C | RNA-Binding Proteins - metabolism | Cancer vaccines | Squamous cell carcinoma | Histocompatibility antigens | Analysis | Liver | Genes | HLA histocompatibility antigens | Colorectal cancer | T cells | Tumors | Peptides | Cytotoxicity | Vaccines | Immunity | CD40L protein | Cancer therapies | Anticancer properties | Metastases | Surgery | Biocompatibility | Physiology | Natural killer cells | Drug dosages | Deoxyribonucleic acid--DNA | Spleen | CD11c antigen | Antigens | Melanoma | Vectors (Biology) | Chemotherapy | Major histocompatibility complex | Pancreatic cancer | Infiltration | Histocompatibility | Haplotypes | Animal models | Colorectal carcinoma | Antibodies | Clinical trials | Oncology | Lymphocytes T | DNA vaccines | Macrophages | Lymph nodes | Granulocytes | Lymphocytes | Colony-stimulating factor | Engineering schools | Cell survival | Dendritic cells | Granulocyte-macrophage colony-stimulating factor | CD4 antigen | Rejection | Lungs | Plasmids | Antigen (tumor-associated) | In vivo methods and tests | Peritoneum | Deoxyribonucleic acid | DNA
Journal Article
International Journal of Cancer, ISSN 0020-7136, 02/2016, Volume 138, Issue 4, pp. 1024 - 1032
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 05/2013, Volume 167, Issue 3, pp. 238 - 247
Journal Article
Clinical & Experimental Metastasis, ISSN 0262-0898, 10/2011, Volume 28, Issue 7, pp. 649 - 659
Previous preclinical and clinical findings have suggested a potential role of epidermal growth factor receptor (EGFR) in osteoclast differentiation and the... 
Biomedicine | Hematology | Tyrosine kinase inhibitor | Oncology | Cancer Research | Osteoclast | Osteolytic bone invasion model | Surgical Oncology | Biomedicine general | Epidermal growth factor receptor | NUDE-MICE | GEFITINIB | REGULATES OSTEOCLAST DIFFERENTIATION | METASTASIS | KINASE INHIBITORS | TUMOR-CELLS | DEFICIENT MICE | ANTITUMOR-ACTIVITY | BREAST-CANCER | ONCOLOGY | GROWTH | Erlotinib Hydrochloride | Humans | Bone Neoplasms - secondary | Male | Bone Neoplasms - pathology | Osteolysis - drug therapy | Bone Neoplasms - metabolism | Receptor, Epidermal Growth Factor - metabolism | Carcinoma, Non-Small-Cell Lung - secondary | Neoplasm Invasiveness - pathology | Bone Neoplasms - drug therapy | Osteolysis - pathology | Disease Models, Animal | Carcinoma, Non-Small-Cell Lung - pathology | Osteoblasts - drug effects | Osteolysis - metabolism | Osteoblasts - pathology | Animals | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Mice | Protein Kinase Inhibitors - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Osteoblasts - metabolism | Quinazolines - pharmacology | Tyrosine | Epidermal growth factor | Erlotinib | Analysis | Oncology, Experimental | Metastasis | Research | Lung cancer, Non-small cell | Vascular endothelial growth factor | Cancer | Research Paper
Journal Article
Journal Article
Molecular Cancer Research, ISSN 1541-7786, 01/2019, Volume 17, Issue 1, pp. 212 - 224
The mechanisms responsible for the development of resistance to alectinib, a second-generation anaplastic lymphoma kinase (ALK) inhibitor, are still unclear,... 
SARACATINIB AZD0530 | GEFITINIB | ONCOGENE | ONCOLOGY | SRC | EML4-ALK FUSION GENE | ACQUIRED-RESISTANCE | CRIZOTINIB | OPEN-LABEL | INHIBITOR | PHASE-I | CELL BIOLOGY
Journal Article
Human Molecular Genetics, ISSN 0964-6906, 08/2005, Volume 14, Issue 16, pp. 2305 - 2321
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 4/2019, Volume 83, Issue 4, pp. 659 - 671
Journal Article
HUMAN MOLECULAR GENETICS, ISSN 0964-6906, 06/2001, Volume 10, Issue 13, pp. 1379 - 1386
Autoimmune thyroid disease (AITD), including Graves' disease (GD) and Hashimoto's thyroiditis (HT), is caused by multiple genetic and environmental factors.... 
CTLA-4 GENE POLYMORPHISM | CAUCASIAN POPULATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | CANDIDATE GENES | CONGENITAL GOITER | GENETICS & HEREDITY | GRAVES-DISEASE | MICROSATELLITE MARKERS | HLA-A | GENOME-WIDE SEARCH | CHROMOSOME 18Q21 | ASSOCIATION
Journal Article
Annals of Oncology, ISSN 0923-7534, 11/2013, Volume 24, Issue suppl 9, pp. ix69 - ix69
Journal Article